Report cover image

Antiarrhythmic Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

Publisher Prof-Research
Published May 25, 2025
Length 90 Pages
SKU # PROF20044929

Description

Antiarrhythmic Drugs Market Summary

and Market Overview

Antiarrhythmic drugs, including sodium channel blockers, beta blockers, potassium channel blockers, calcium channel blockers, and others, address cardiovascular conditions like atrial fibrillation (AF), affecting 33 million people globally, and ventricular arrhythmias. The market is driven by an aging population (1 billion over 60 in 2020, projected to reach 2.1 billion by 2050), with AF prevalence reaching 10-17% in those over 65. Lifestyle factors like hypertension (1.2 billion cases) and diabetes (422 million cases) increase arrhythmia risk. Novel drugs like AP30663 and sustained-release propafenone improve compliance by 20%. The global antiarrhythmic drugs market is estimated at USD 600-1,200 million in 2025, with a CAGR of 4%-8% through 2030.

Regional Market Trends
North America: The U.S. leads with high AF prevalence and novel drug adoption, while Canada focuses on preventive care.
Europe: Germany, France, and the UK drive growth with advanced cardiology care.
Asia Pacific: China and Japan see rising cases due to aging, with India emphasizing generics.
Rest of the World: Brazil expands CVD treatment access, while the Middle East addresses lifestyle-related arrhythmias.

Distribution Channel Analysis
Hospital Pharmacies: Expected growth of 4.5%-8.5%, driven by acute arrhythmia cases. Trends focus on ICU delivery.
Retail Pharmacies: Projected growth of 4.0%-8.0%, linked to chronic management. Advances emphasize accessibility.
Others: Anticipated growth of 3.8%-7.8%, covering online platforms. Trends highlight digital prescriptions.

Type Analysis
Sodium Channel Blockers: Expected growth of 4.0%-8.0%, for ventricular arrhythmias. Trends focus on propafenone improvements.
Beta Blockers: Projected growth of 4.2%-8.2%, widely used for AF. Advances emphasize long-acting formulations.
Potassium Channel Blockers: Anticipated growth of 4.5%-8.5%, effective for AF conversion. Trends highlight sotalol innovations.
Calcium Channel Blockers: Expected growth of 4.0%-8.0%, for rate control. Developments prioritize safety profiles.
Others: Projected growth of 3.8%-7.8%, covering novel agents. Trends focus on SK channel inhibitors.

Key Market Players
Pfizer: Offers beta blockers for arrhythmia management.
Sanofi: Supplies antiarrhythmic therapies for AF.
Novartis: Develops calcium channel blockers.
Merck: Provides potassium channel blockers.
GSK: Innovates arrhythmia treatments.

Porter’s Five Forces Analysis
Threat of New Entrants: Moderate, as high R&D costs exist, but generics lower barriers.
Threat of Substitutes: Moderate, with non-pharmacological treatments like ablation competing, but drugs are essential for acute cases.
Bargaining Power of Buyers: High, due to generic availability driving price competition.
Bargaining Power of Suppliers: Low, with multiple suppliers of active ingredients.
Competitive Rivalry: High, with companies competing on efficacy, safety, and cost.

Market Opportunities and Challenges

Opportunities:
Addressing 33 million AF patients globally.
Targeting an aging population, with 10-17% AF prevalence.
Leveraging novel drugs, improving compliance by 20%.
Managing lifestyle-driven arrhythmias, with 1.2 billion hypertension cases.
Expanding generic antiarrhythmic options.
Supporting ICU arrhythmia management, with 30% prevalence.

Challenges:
Price erosion due to generic competition.
Side effects of antiarrhythmic drugs requiring monitoring.
Competition from ablation procedures.
Regulatory delays for novel therapies.
Limited access in low-income regions.

Table of Contents

90 Pages
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Antiarrhythmic Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Antiarrhythmic Drug Market in North America (2020-2030)
8.1 Antiarrhythmic Drug Market Size
8.2 Antiarrhythmic Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Antiarrhythmic Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Antiarrhythmic Drug Market in South America (2020-2030)
9.1 Antiarrhythmic Drug Market Size
9.2 Antiarrhythmic Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Antiarrhythmic Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Antiarrhythmic Drug Market in Asia & Pacific (2020-2030)
10.1 Antiarrhythmic Drug Market Size
10.2 Antiarrhythmic Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Antiarrhythmic Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Antiarrhythmic Drug Market in Europe (2020-2030)
11.1 Antiarrhythmic Drug Market Size
11.2 Antiarrhythmic Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Antiarrhythmic Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Antiarrhythmic Drug Market in MEA (2020-2030)
12.1 Antiarrhythmic Drug Market Size
12.2 Antiarrhythmic Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Antiarrhythmic Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Antiarrhythmic Drug Market (2020-2025)
13.1 Antiarrhythmic Drug Market Size
13.2 Antiarrhythmic Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Antiarrhythmic Drug Market Size by Type
Chapter 14 Global Antiarrhythmic Drug Market Forecast (2025-2030)
14.1 Antiarrhythmic Drug Market Size Forecast
14.2 Antiarrhythmic Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Antiarrhythmic Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Antiarrhythmic Drug Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Antiarrhythmic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.2 Sanofi
15.2.1 Company Profile
15.2.2 Main Business and Antiarrhythmic Drug Information
15.2.3 SWOT Analysis of Sanofi
15.2.4 Sanofi Antiarrhythmic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.3 Novartis
15.3.1 Company Profile
15.3.2 Main Business and Antiarrhythmic Drug Information
15.3.3 SWOT Analysis of Novartis
15.3.4 Novartis Antiarrhythmic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.4 Merck
15.4.1 Company Profile
15.4.2 Main Business and Antiarrhythmic Drug Information
15.4.3 SWOT Analysis of Merck
15.4.4 Merck Antiarrhythmic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.5 GSK
15.5.1 Company Profile
15.5.2 Main Business and Antiarrhythmic Drug Information
15.5.3 SWOT Analysis of GSK
15.5.4 GSK Antiarrhythmic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.6 Viatris
15.6.1 Company Profile
15.6.2 Main Business and Antiarrhythmic Drug Information
15.6.3 SWOT Analysis of Viatris
15.6.4 Viatris Antiarrhythmic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.7 Baxter International
15.7.1 Company Profile
15.7.2 Main Business and Antiarrhythmic Drug Information
15.7.3 SWOT Analysis of Baxter International
15.7.4 Baxter International Antiarrhythmic Drug Revenue, Gross Margin and Market Share (2020-2025)
15.8 Mayne Pharma
15.8.1 Company Profile
15.8.2 Main Business and Antiarrhythmic Drug Information
15.8.3 SWOT Analysis of Mayne Pharma
15.8.4 Mayne Pharma Antiarrhythmic Drug Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Antiarrhythmic Drug Report
Table Data Sources of Antiarrhythmic Drug Report
Table Major Assumptions of Antiarrhythmic Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Antiarrhythmic Drug Picture
Table Antiarrhythmic Drug Classification
Table Antiarrhythmic Drug Applications
Table Drivers of Antiarrhythmic Drug Market
Table Restraints of Antiarrhythmic Drug Market
Table Opportunities of Antiarrhythmic Drug Market
Table Threats of Antiarrhythmic Drug Market
Table Covid-19 Impact For Antiarrhythmic Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Antiarrhythmic Drug
Table Cost Structure Analysis of Antiarrhythmic Drug
Table Key End Users
Table Latest News of Antiarrhythmic Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Antiarrhythmic Drug Market
Table Policy of Antiarrhythmic Drug Market
Table 2020-2030 North America Antiarrhythmic Drug Market Size
Figure 2020-2030 North America Antiarrhythmic Drug Market Size and CAGR
Table 2020-2030 North America Antiarrhythmic Drug Market Size by Application
Table 2020-2025 North America Antiarrhythmic Drug Key Players Revenue
Table 2020-2025 North America Antiarrhythmic Drug Key Players Market Share
Table 2020-2030 North America Antiarrhythmic Drug Market Size by Type
Table 2020-2030 United States Antiarrhythmic Drug Market Size
Table 2020-2030 Canada Antiarrhythmic Drug Market Size
Table 2020-2030 Mexico Antiarrhythmic Drug Market Size
Table 2020-2030 South America Antiarrhythmic Drug Market Size
Figure 2020-2030 South America Antiarrhythmic Drug Market Size and CAGR
Table 2020-2030 South America Antiarrhythmic Drug Market Size by Application
Table 2020-2025 South America Antiarrhythmic Drug Key Players Revenue
Table 2020-2025 South America Antiarrhythmic Drug Key Players Market Share
Table 2020-2030 South America Antiarrhythmic Drug Market Size by Type
Table 2020-2030 Brazil Antiarrhythmic Drug Market Size
Table 2020-2030 Argentina Antiarrhythmic Drug Market Size
Table 2020-2030 Chile Antiarrhythmic Drug Market Size
Table 2020-2030 Peru Antiarrhythmic Drug Market Size
Table 2020-2030 Asia & Pacific Antiarrhythmic Drug Market Size
Figure 2020-2030 Asia & Pacific Antiarrhythmic Drug Market Size and CAGR
Table 2020-2030 Asia & Pacific Antiarrhythmic Drug Market Size by Application
Table 2020-2025 Asia & Pacific Antiarrhythmic Drug Key Players Revenue
Table 2020-2025 Asia & Pacific Antiarrhythmic Drug Key Players Market Share
Table 2020-2030 Asia & Pacific Antiarrhythmic Drug Market Size by Type
Table 2020-2030 China Antiarrhythmic Drug Market Size
Table 2020-2030 India Antiarrhythmic Drug Market Size
Table 2020-2030 Japan Antiarrhythmic Drug Market Size
Table 2020-2030 South Korea Antiarrhythmic Drug Market Size
Table 2020-2030 Southeast Asia Antiarrhythmic Drug Market Size
Table 2020-2030 Australia Antiarrhythmic Drug Market Size
Table 2020-2030 Europe Antiarrhythmic Drug Market Size
Figure 2020-2030 Europe Antiarrhythmic Drug Market Size and CAGR
Table 2020-2030 Europe Antiarrhythmic Drug Market Size by Application
Table 2020-2025 Europe Antiarrhythmic Drug Key Players Revenue
Table 2020-2025 Europe Antiarrhythmic Drug Key Players Market Share
Table 2020-2030 Europe Antiarrhythmic Drug Market Size by Type
Table 2020-2030 Germany Antiarrhythmic Drug Market Size
Table 2020-2030 France Antiarrhythmic Drug Market Size
Table 2020-2030 United Kingdom Antiarrhythmic Drug Market Size
Table 2020-2030 Italy Antiarrhythmic Drug Market Size
Table 2020-2030 Spain Antiarrhythmic Drug Market Size
Table 2020-2030 Belgium Antiarrhythmic Drug Market Size
Table 2020-2030 Netherlands Antiarrhythmic Drug Market Size
Table 2020-2030 Austria Antiarrhythmic Drug Market Size
Table 2020-2030 Poland Antiarrhythmic Drug Market Size
Table 2020-2030 Russia Antiarrhythmic Drug Market Size
Table 2020-2030 MEA Antiarrhythmic Drug Market Size
Figure 2020-2030 MEA Antiarrhythmic Drug Market Size and CAGR
Table 2020-2030 MEA Antiarrhythmic Drug Market Size by Application
Table 2020-2025 MEA Antiarrhythmic Drug Key Players Revenue
Table 2020-2025 MEA Antiarrhythmic Drug Key Players Market Share
Table 2020-2030 MEA Antiarrhythmic Drug Market Size by Type
Table 2020-2030 Egypt Antiarrhythmic Drug Market Size
Table 2020-2030 Israel Antiarrhythmic Drug Market Size
Table 2020-2030 South Africa Antiarrhythmic Drug Market Size
Table 2020-2030 Gulf Cooperation Council Countries Antiarrhythmic Drug Market Size
Table 2020-2030 Turkey Antiarrhythmic Drug Market Size
Table 2020-2025 Global Antiarrhythmic Drug Market Size by Region
Table 2020-2025 Global Antiarrhythmic Drug Market Size Share by Region
Table 2020-2025 Global Antiarrhythmic Drug Market Size by Application
Table 2020-2025 Global Antiarrhythmic Drug Market Share by Application
Table 2020-2025 Global Antiarrhythmic Drug Key Vendors Revenue
Figure 2020-2025 Global Antiarrhythmic Drug Market Size and Growth Rate
Table 2020-2025 Global Antiarrhythmic Drug Key Vendors Market Share
Table 2020-2025 Global Antiarrhythmic Drug Market Size by Type
Table 2020-2025 Global Antiarrhythmic Drug Market Share by Type
Table 2025-2030 Global Antiarrhythmic Drug Market Size by Region
Table 2025-2030 Global Antiarrhythmic Drug Market Size Share by Region
Table 2025-2030 Global Antiarrhythmic Drug Market Size by Application
Table 2025-2030 Global Antiarrhythmic Drug Market Share by Application
Table 2025-2030 Global Antiarrhythmic Drug Key Vendors Revenue
Figure 2025-2030 Global Antiarrhythmic Drug Market Size and Growth Rate
Table 2025-2030 Global Antiarrhythmic Drug Key Vendors Market Share
Table 2025-2030 Global Antiarrhythmic Drug Market Size by Type
Table 2025-2030 Antiarrhythmic Drug Global Market Share by Type

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us